seed
Stage
2
Investors
About
GELMEDIX develops regenerative medicine therapies to restore vision loss by regenerating damaged retinal cells, using proprietary injectable hydrogel scaffolds to improve delivery and efficacy of cell and gene therapies for degenerative eye diseases.
Explore GELMEDIX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.